2021
DOI: 10.3390/medicina57050510
|View full text |Cite
|
Sign up to set email alerts
|

European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe

Abstract: Designed by a group of ME/CFS researchers and health professionals, the European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE) has received funding from the European Cooperation in Science and Technology (COST)—COST action 15111—from 2016 to 2020. The main goal of the Cost Action was to assess the existing knowledge and experience on health care delivery for people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in European countries, and to enhance coordinated resea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

7
111
0
28

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
3

Relationship

3
5

Authors

Journals

citations
Cited by 126 publications
(180 citation statements)
references
References 63 publications
7
111
0
28
Order By: Relevance
“…Research points to multi-faceted causes of ME/CFS with 72% of patients reporting an infectious illness at the onset of the disease [ 26 ]. To date, there is no diagnostic biomarker or curative treatment [ 27 , 28 , 29 ]. However, during the last decades the DePaul Symptom Questionnaire (DSQ) has been developed as a valid and reliable psychometric instrument to assess ME/CFS symptoms [ 30 ].…”
Section: Introductionmentioning
confidence: 99%
“…Research points to multi-faceted causes of ME/CFS with 72% of patients reporting an infectious illness at the onset of the disease [ 26 ]. To date, there is no diagnostic biomarker or curative treatment [ 27 , 28 , 29 ]. However, during the last decades the DePaul Symptom Questionnaire (DSQ) has been developed as a valid and reliable psychometric instrument to assess ME/CFS symptoms [ 30 ].…”
Section: Introductionmentioning
confidence: 99%
“…Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complicated, chronic disease mainly characterized by severe fatigue with many clinical symptoms related to autonomic nervous system imbalance, cognitive impairment, immune and endocrine dysfunction [1]. The prevalence of ME/CFS worldwide varies from 0.1% up to 2.2% depending on the applied diagnostic criteria [2][3][4]. However, there are no European-wide estimates of disease burden [5].…”
Section: Introductionmentioning
confidence: 99%
“…As to the statistics of ME/CFS, the numbers vary and depend on the country and research. The prevalence is from 0.42% to 2.54% worldwide [ 5 ] and there are from one million to over five million people suffering from ME/CFS in Europe [ 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…In the last 30 to 40 years approximately 20 different diagnostic criteria systems have been proposed. One of the most commonly used is the Fukuda criteria (FC) [ 7 ], more recently the Canadian Consensus Criteria (CCC) [ 8 ] have been proposed, as well as the International Consensus Criteria (ICC) [ 1 ], the Oxford criteria (OC) [ 9 ] and the criteria released by the IOM in 2015 [ 10 ], the latter having received international recognition [ 4 ]. FC (1994) commonly serves as a diagnostic tool in research purposes.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation